Demarin Vida, Vuković Vlasta
Klinika za neurologiju, Referentni centar za neurovaskularne poremećaje Ministarstva zdravstva i socijalne skrbi RH, Klinicka bolnica Sestre milosrdnice , Zagreb, Hrvatska.
Acta Med Croatica. 2008 May;62(2):137-40.
According to World Health Organization migraine is ranked among the first 20 disorders in the world that cause significant disability. The economic burden due to migraine is significant; direct costs include visits to general practitioner and emergency department, costs of hospitalization and pharmacotherapy. Indirect costs comprise 2/3 of total costs and include absenteeism from work and costs due to reduced productivity. Reasons for the high economic burden are primarily insufficient diagnosing of migraine, the lack of information in the general population, underdevelopment of healthcare system and non-existence of plans and programms for a systematic approach in the management of headaches. Triptans as a specific and very efficient therapy for migraine are available on the market; studies have shown a high benefit-to-cost ratio when triptans were introduced as an acute therapy of migraine attacks. More attention should be paid to better diagnosis and treatment of headaches, especially migraine. We propose the main aspects for improvement of healthcare for patients with headaches.
根据世界卫生组织的数据，偏头痛在全球导致严重残疾的20种疾病中名列前茅。偏头痛造成的经济负担十分巨大；直接成本包括看全科医生和急诊的费用、住院费用以及药物治疗费用。间接成本占总成本的三分之二，包括旷工以及因生产力下降产生的成本。经济负担高昂的主要原因包括偏头痛诊断不足、普通人群缺乏相关信息、医疗体系不发达以及缺乏针对头痛进行系统管理的计划和方案。曲坦类药物作为一种治疗偏头痛的特效且高效的疗法已投放市场；研究表明，将曲坦类药物作为偏头痛发作的急性疗法时，效益成本比很高。应更加关注头痛尤其是偏头痛的更好诊断和治疗。我们提出了改善头痛患者医疗保健的主要方面。
